Autologous NK cell therapy for reproductive failure
Part of Women’s health & pregnancy clinical trials.
This study tests whether a special type of your own natural killer (NK) cells—turned into 'decidual-like' cells—can help people who've had repeated pregnancy losses or failed IVF. The goal is to improve the chance of a successful pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had trouble getting pregnant or carrying a baby, and a test has shown abnormal natural killer (NK) cells in your menstrual blood.
- You want to become pregnant now.
- Your ovaries are working normally, or if you have early ovarian aging, you have at least 2 high-quality frozen embryos ready for transfer.
- Your womb lining (endometrium) is at least 7 mm thick around the time of ovulation, checked by ultrasound.
- Your body mass index (BMI) is between 18 and 28.
- You are willing to follow the study's check-up schedule.
- You are not taking any medications that block progesterone, and you do not have severe endometriosis, fibroids, or other major uterine conditions.
- You have no uncontrolled autoimmune or hormone disorders, no history of cancer, and you are not allergic to blood products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment using your own immune cells (natural killer cells) to improve pregnancy chances. It's for women with infertility, repeated miscarriages, or other pregnancy complications linked to abnormal natural killer cell function.
This trial tests a new therapy that uses your own natural killer (NK) cells, modified to better fight cancer and injected directly into your abdomen. It's for people with advanced ovarian cancer who cannot have surgery or whose tumor cannot be fully removed.
This trial tests a personalized immune treatment made from your own NK cells (a type of blood-fighting immune cell) for relapsed or refractory B-cell non-Hodgkin lymphoma. It aims to check safety and whether the treatment can shrink lymphoma and help control the disease.
This trial tests a new type of immune cell therapy (CIML NK cells) given directly into the abdomen for women with ovarian cancer that has come back and is now resistant to standard platinum chemotherapy. The goal is to see if these specially trained cells can fight the cancer safely.
This trial studies whether placing your own immune cells (PBMCs) that have been adjusted with a medicine called IFN-<i>t</i> before embryo transfer can improve IVF success. It may help support the uterine environment around the time of implantation.
This trial tests a new natural killer (NK) cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to treatment. The therapy targets two specific markers (CLL1 or CD33) on leukemia cells. It aims to see if these immune cells can safely fight the cancer.
Hear when a new Infertility Unexplained trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.